Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo

Gene Therapy volume 14, pages 989–997 (2007)Cite this article

A Corrigendum to this article was published on 19 June 2007

Abstract

Recombinant adeno-associated (AAV) viruses have unique properties, which make them ideal vectors for gene transfer targeting the myocardium. Numerous serotypes of AAV have been identified with variable tropisms towards cardiac tissue. In the present study, we investigated the time course of expression of eight different AAV serotypes in rat myocardium and the nature of the immunity against these serotypes. We first assessed whether neutralizing antibodies (NAb) were present for any of the serotype in the rats. We injected 100 μl of each AAV 1–8 serotype (1012 DNAse resistant particles/ml), encoding LacZ gene, into the apical wall of rat myocardium. At 1, 4, 12 and 24 weeks after gene delivery, the animals were killed and β-galactosidase (β-gal) activity was assessed by luminometry. Additionally, LacZ genomic copies and AAV capsids copies were measured through standard polymerase chain reaction analysis and cryo-sections from the area of viral injection were stained for X-gal detection at the same time points. No NAbs were detected against any of AAV serotypes. At all the time points studied, AAV1, 6 and 8 demonstrated the highest efficiency in transducing rat hearts in vivo. Parallel to the results with β-gal activity, the highest levels LacZ and AAV DNA genomic copies were with AAV1, 6 and 8. The positive X-gal staining depicted by these serotypes confirmed these results. These results indicate that among the various AAV serotypes, AAV1, 6 and 8 have differential tropism for the heart unaffected by pre-existing NAb in the rat. Although AAV 1 and 6 vectors induced rapid and robust expression and reach a plateau at 4 weeks, AAV 8 continued increasing until the end of the study. AAV 2, 5 and 7 vectors were slower to induce expression of the reporter gene, but did reach levels of expression comparable to AAV1 and AAV6 vectors after 3 months.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. del Monte F, Hajjar RJ, Harding SE . Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res 2001; 88: E66–E67.

    Article  CAS  Google Scholar 

  2. del Monte F, Williams E, Lebeche D, Schmidt U, Rosenzweig A, Gwathmey JK et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 2001; 104: 1424–1429.

    Article  CAS  Google Scholar 

  3. del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ . Targeting phospholamban by gene transfer in human heart failure. Circulation 2002; 105: 904–907.

    Article  CAS  Google Scholar 

  4. Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 10405–10410.

    Article  CAS  Google Scholar 

  5. Berns KI, Adler S . Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol 1972; 9: 394–396.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Buller RM, Janik JE, Sebring ED, Rose JA . Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol 1981; 40: 241–247.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Berns KI, Giraud C . Adenovirus and adeno-associated virus as vectors for gene therapy. Ann N Y Acad Sci 1995; 772: 95–104.

    Article  CAS  Google Scholar 

  8. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997; 3: 306–312.

    Article  CAS  Google Scholar 

  9. Vincent-Lacaze N, Snyder RO, Gluzman R, Bohl D, Lagarde C, Danos O . Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol 1999; 73: 1949–1955.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Bessis N, GarciaCozar FJ, Boissier MC . Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Therapy 2004; 11 (Suppl 1): S10–S17.

    Article  CAS  Google Scholar 

  11. Carter BJ . Adeno-associated virus vectors in clinical trials. Hum Gene Ther 2005; 16: 541–550.

    Article  CAS  Google Scholar 

  12. Croteau GA, Martin DB, Camp J, Yost M, Conrad C, Zeitlin PL et al. Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis. Ann Occup Hyg 2004; 48: 673–681.

    PubMed  Google Scholar 

  13. Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004; 15: 93–128.

    Article  Google Scholar 

  14. Rutledge EA, Halbert CL, Russell DW . Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309–319.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854–11859.

    Article  CAS  Google Scholar 

  16. Muramatsu S, Mizukami H, Young NS, Brown KE . Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 1996; 221: 208–217.

    Article  CAS  Google Scholar 

  17. Chiorini JA, Kim F, Yang L, Kotin RM . Cloning and characterization of adeno-associated virus type 5. J Virol 1999; 73: 1309–1319.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Chiorini JA, Yang L, Liu Y, Safer B, Kotin RM . Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997; 71: 6823–6833.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y et al. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 2004; 113: 727–736.

    Article  CAS  Google Scholar 

  20. Su H, Joho S, Huang Y, Barcena A, Arakawa-Hoyt J, Grossman W et al. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc Natl Acad Sci USA 2004; 101: 16280–16285.

    Article  CAS  Google Scholar 

  21. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002; 105: 602–607.

    Article  CAS  Google Scholar 

  22. Vassalli G, Bueler H, Dudler J, von Segesser LK, Kappenberger L . Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 2003; 90: 229–238.

    Article  Google Scholar 

  23. Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J . Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574–1583.

    Article  CAS  Google Scholar 

  24. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56–63.

    Article  CAS  Google Scholar 

  25. Bantel-Schaal U, Delius H, Schmidt R, zur Hausen H . Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol 1999; 73: 939–947.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD . Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524–1532.

    Article  CAS  Google Scholar 

  27. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM . Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994–4003.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE . Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619–623.

    Article  CAS  Google Scholar 

  29. Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 2004; 10: 671–678.

    Article  CAS  Google Scholar 

  30. Du L, Kido M, Lee DV, Rabinowitz JE, Samulski RJ, Jamieson SW et al. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors. Mol Ther 2004; 10: 604–608.

    Article  CAS  Google Scholar 

  31. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005; 23: 321–328.

    Article  CAS  Google Scholar 

  32. Louboutin JP, Wang L, Wilson JM . Gene transfer into skeletal muscle using novel AAV serotypes. J Gene Med 2004; 7: 442–451.

    Article  Google Scholar 

  33. Kawamoto S, Shi Q, Nitta Y, Miyazaki J, Allen MD . Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter. Mol Ther 2005; 11: 980–985.

    Article  CAS  Google Scholar 

  34. Anyukhovsky EP, Sosunov EA, Rosen MR . Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations. Circulation 1996; 94: 1981–1988.

    Article  CAS  Google Scholar 

  35. Liu DW, Gintant GA, Antzelevitch C . Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res 1993; 72: 671–687.

    Article  CAS  Google Scholar 

  36. Di Diego JM, Sun ZQ, Antzelevitch C . I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol 1996; 271: H548–H561.

    CAS  PubMed  Google Scholar 

  37. Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S . Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol 2002; 283: H1031–H1041.

    Article  CAS  Google Scholar 

  38. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996; 78: 262–273.

    Article  CAS  Google Scholar 

  39. Akar FG, Rosenbaum DS . Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res 2003; 93: 638–645.

    Article  CAS  Google Scholar 

  40. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428–3432.

    Article  CAS  Google Scholar 

  41. Zabner J, Seiler M, Walters R, Kotin RM, Fulgeras W, Davidson BL et al. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 2000; 74: 3852–3858.

    Article  CAS  Google Scholar 

  42. Di Pasquale G, Davidson BL, Stein CS, Martins I, Scudiero D, Monks A et al. Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med 2003; 9: 1306–1312.

    Article  CAS  Google Scholar 

  43. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA . Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 2001; 75: 6884–6893.

    Article  CAS  Google Scholar 

  44. Cottard V, Valvason C, Falgarone G, Lutomski D, Boissier MC, Bessis N . Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes. J Clin Immunol 2004; 24: 162–169.

    Article  CAS  Google Scholar 

  45. Moskalenko M, Chen L, van Roey M, Donahue BA, Snyder RO, McArthur JG et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol 2000; 74: 1761–1766.

    Article  CAS  Google Scholar 

  46. Peden CS, Burger C, Muzyczka N, Mandel RJ . Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J Virol 2004; 78: 6344–6359.

    Article  CAS  Google Scholar 

  47. Sanftner LM, Suzuki BM, Doroudchi MM, Feng L, McClelland A, Forsayeth JR et al. Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV. Mol Ther 2004; 9: 403–409.

    Article  CAS  Google Scholar 

  48. Erles K, Sebokova P, Schlehofer JR . Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999; 59: 406–411.

    Article  CAS  Google Scholar 

  49. Sandalon Z, Bruckheimer EM, Lustig KH, Rogers LC, Peluso RW, Burstein H . Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J Virol 2004; 78: 12355–12365.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by NIH grants HL 57263, HL 71763, HL 078691, and HL 080498 (to Roger J. Hajjar) and a Leducq transatlantic foundation grant.

Author information

Authors and Affiliations

  1. Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    J Palomeque, E R Chemaly, F del Monte & R J Hajjar

  2. Avigen Inc., Alameda, CA, USA

    P Colosi, J A Wellman & S Zhou

Authors
  1. J Palomeque
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E R Chemaly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Colosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J A Wellman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F del Monte
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R J Hajjar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R J Hajjar.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palomeque, J., Chemaly, E., Colosi, P. et al. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther 14, 989–997 (2007). https://doi.org/10.1038/sj.gt.3302895

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302895

Keywords

This article is cited by

Search

Advanced search

Quick links